IGC Pharma (IGC) EV to CFO (2010 - 2025)
IGC Pharma's (IGC) quarterly EV to CFO came in at 27.34 in Q3 2025, up 12.64% year-over-year from 24.27 in Q3 2024, and down 130.99% quarter-over-quarter from 11.84 in Q2 2025.
Powered by 
Analysis
IGC Pharma (IGC) EV to CFO (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported EV to CFO for 16 consecutive years, with 27.34 the latest figure, recorded in Q3 2025.
- On a quarterly basis, EV to CFO rose 12.64% year-over-year to 27.34 in Q3 2025; TTM through Sep 2025 was 6.71, a 4.59% decrease from a year earlier, with the FY2026 full-year figure at 21.03, down 345.31% from the prior year.
- EV to CFO was 27.34 for Q3 2025 at IGC Pharma, down from 11.84 in the prior quarter.
- Over five years, EV to CFO peaked at 7.14 in Q4 2022 and troughed at 48.43 in Q1 2024.
- A 5-year average of 21.23 and a median of 17.69 in 2024 frame the typical range for EV to CFO.
- Across the five-year window, EV to CFO plunged 740.93% in 2021 and soared 77.66% in 2023, its largest moves.
- Over 5 years, EV to CFO stood at 15.65 in 2021, then jumped by 54.4% to 7.14 in 2022, then plunged by 45.43% to 10.38 in 2023, then tumbled by 88.76% to 19.59 in 2024, then sank by 39.53% to 27.34 in 2025.
- The last three EV to CFO figures came in at 27.34 (Q3 2025), 11.84 (Q2 2025), and 31.02 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | IGC Pharma | 27.77 Mn | 27.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -27.34 |
| Jun 30, 2025 | -11.84 |
| Mar 31, 2025 | -31.02 |
| Dec 31, 2024 | -19.59 |
| Sep 30, 2024 | -31.30 |
| Jun 30, 2024 | -17.69 |
| Mar 31, 2024 | -48.43 |
| Dec 31, 2023 | -10.38 |
| Sep 30, 2023 | -12.16 |
| Jun 30, 2023 | -9.78 |
| Mar 31, 2023 | -9.57 |
| Dec 31, 2022 | -7.14 |
| Sep 30, 2022 | -9.42 |
| Jun 30, 2022 | -8.84 |
| Mar 31, 2022 | -42.82 |
| Dec 31, 2021 | -15.65 |
| Sep 30, 2021 | -26.56 |
| Jun 30, 2021 | -35.58 |
| Mar 31, 2021 | -28.34 |
| Dec 31, 2020 | -33.32 |